Global Circulating Tumor Cells Market Size Projected to Surpass USD 30.78 Billion by 2029: Polaris Market Research

According to the latest research study, the report predicts the global size & share of Circulating Tumor Cells Market to reach around USD 30.78 Billion By 2029 from USD 10.68 Billion in 2021. The global Circulating Tumor Cells Market is anticipated to register a significant CAGR of 14.9% by 2029.

According to the latest research study, the report predicts the global size & share of Circulating Tumor Cells Market to reach around USD 30.78 Billion By 2029 from USD 10.68 Billion in 2021. The global Circulating Tumor Cells Market is anticipated to register a significant CAGR of 14.9% by 2029.

Circulating tumor cells have disconnected from a principal tumor and spread in the bloodstream. CTCs can be contemplated as seeds for the successive growth of supplemental tumors. Thus CTCs are competent in metastasizing to additional body areas and may generate new tumors in several organs and tissues. With the advancement of new technologies of genome sequencing, molecular imaging, metastasis model establishment, and single-cell analysis the metastasis procedures have been illustrated to be persuaded by the CTCs entailing tissues that are distant and need familiarization in niche and leaving behind the host organs.

Many CTCs have variable morphologies, including their cell size, nucleus, cytoplasmic features, and fragmentations and clusters of cells. These differences in morphology and cellular characteristics can be crucial in recognizing the therapeutic and prognostic implications for the disease. The growing demand for treatment options for patients having metastasis carcinoma has generated a collateral need for new procedures to monitor their use. Preferably, these procedures would be chronic, being unconstrained of treatment, and offer calculable real-time analysis of interest in many carcinomas. Evaluation of CTCs fused into the blood in the course of metastasis may satiate this requirement.

Request Sample Copy of Research Report @

Our Sample Report Includes:

Covid-19 pandemic outbreak impact analysis included
2021 upgraded report preface, overview, and detailed, in-depth industry analysis
175+ pages research report
Offer chapter wise instruction on request
Includes updated regional scrutinizing with the graphical representation of share, size, and trends.
The report offers top market players their sales volume, business strategy, and revenue analysis


Key offerings

Market size and forecast by revenue (2021β€”2028)
Market dynamics – Prime trends, restraints, growth drivers, and opportunities of investment
Market segmentation – A detailed analysis by source, product, distribution channel, and region
Competitive landscape – vendors that are crucial and topmost


Top Market Players

AVIVA Biosciences BioCEP Ltd
Biolidics Limited
Bio-Techne Corporation
Canopus Bioscience Ltd.
Creativ MicroTech Inc.
Epic Sciences
Fluxion Biosciences Inc.
Greiner Bio-One International GmbH
Ikonisys Inc
LineaRx Inc. (Vitatex Inc.)
LungLife AI Inc.
Menarini Silicon Biosystems
Miltenyi Biotec
Precision for Medicine
Rarecells Diagnostics
STEMCELL Technologies Inc.
Sysmex Corporation


Inquire more about this report before purchase @

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Important Questions Being Answered by The Market Report

What is the global circulating tumor cells market size and growth?
Which segment is responsible for the largest global circulating tumor cells market share?
Who are the critical players?
What are the factors pushing the market?
What are the current trends that will impact the market in the coming years?
What are the estimates of the future that would assist in taking further strategic measures?


Circulating Tumor Cells Market: Growth Leading Factors

Increasing demand for marginally interfering diagnostic procedures is expected to push investments by essential stakeholders in the region. Circulating tumor cells dependent liquid biopsy tests accelerate restrictive trauma and sanction recovery that is rapid because of its noninvasive nature. Further, it sanctions the slightest invasive screening of tumors before selecting a combination of surgical procedures like chemotherapy, radiotherapy, surgical ejection of tumors, thus positively influencing adoption.

The demand for circulating tumor cells market is because of the increasing predominance of cancer. Cancer is one of the prominent reasons for death worldwide. There is an increase in genetic disorders, smoking, alcohol consumption, and lifestyle are the major factors in the rise in cancer cases and therefore push the growth of the circulating tumor cells market.

Due to covid-19, pharmaceutical and biotech companies with governments worldwide are working to meet the covid-19 outbreak by reinforcing the advancement of vaccines to arrange for medicine supply chain provocations. Also, frequently used drugs like hydroxyl chloroquine have seen a considerable rise in the demand for covid-19 management as many developed countries encounter drug shortages. Therefore, the biotechnology and pharmaceutical firms are anticipated to witness a noteworthy development in the future because of the demand for vaccine and treatment drugs for covid-19.

Global Circulating Tumor Cells Market: Report Scope

Report Attribute


Market Size 2021 Value

USD 10.68 Billion

Market Outlook for 2029

USD 30.78 Billion

Expected CAGR Growth

14.9% from 2022 – 2029

Base year


Forecast period

2022 – 2029

Segments covered

By Technology, By Application, By Product, By Specimen, By Region

Key Companies

AVIVA Biosciences BioCEP Ltd, BIOCEPT, Inc., BioFluidica, Biolidics Limited, Bio-Techne Corporation, Canopus Bioscience Ltd., Creativ MicroTech, Inc., Epic Sciences, Fluxion Biosciences, Inc., Greiner Bio-One International GmbH, Ikonisys Inc, IVDiagnostics, LineaRx, Inc. (Vitatex, Inc.), LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec, Precision for Medicine, QIAGEN, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation.

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Customization Options

Customized purchase options are available to meet your research needs.


Request Customized Copy of Report @

(We customize your report according to your research need. Ask our sales team for report customization.)

Circulating Tumor Cells Market: Key Segmentation

Insight by technology, application, product, specimen, and region

By technology, the CTC enrichment method is additionally divided into negative and positive enrichment and other technologies. The size of the industry from enrichment segment that is negative will develop with growing penetration in diagnostic centers to provide better productivity in observation. By application, the collective chromosome deviation segment in the market will witness growth because of expanding circumstances of aneuploidy. By product, the segment and devices influenced the market in context to its revenue share over its equivalent components and reagents and kits and tubes for blood collection. By specimen, an extensive cluster of these cells in a sample of blood in contrast with alternative biospecimens is accountable for the biggest perforation of this specimen size.

By region, North America dominated the global circulating tumor cells market and assumed the most significant share because of the increasing existence of cancer in the area. The cancer care infrastructure is advanced by many research firms’ initiatives for modern technologies. The prevalence of skilled workers and more extraordinary healthcare expenses will dimension the regional expansion. The Asia Pacific is estimated to bloom at a rate that is lucrative with the needs of a high unmet diagnostics besides swiftly growing awareness of the patient in context to the untimely investigation of cancer and assessment of risk.

Browse the full β€œCirculating Tumor Cells Market Share, Size, Trends, Industry Analysis Report, By Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis); By Application (Clinical/Liquid Biopsy, Research); By Product; By Specimen; By Region; Segment Forecast, 2022 – 2029” Report at

The market primarily depends on technology, application, product, specimen, and region

Circulating Tumor Cells Market: By Technology

Circulating Tumor Cells Detection & Enrichment Methods
Size-based Separation
Density-based Separation
Combined Methods
Circulating Tumor Cells Direct Detection Methods
Circulating Tumor Cells Analysis


Circulating Tumor Cells Market: By Application

Clinical/ Liquid Biopsy


Circulating Tumor Cells Market: By Product

Kits & Reagents
Blood Collection Tubes
Devices or Systems


Circulating Tumor Cells Market: By Specimen

Bone Marrow
Other Body Fluids


About Us:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Media Contact
Company Name: Polaris Market Research and Consulting
Contact Person: Likhil
Email: Send Email
Phone: +1-9292-97-97-27
Address:30 Wall Street 8th Floor, New York City, NY 10005, United States
City: New York City
State: US
Country: United States